🇺🇸 FDA

Intelligence Platform

Patents

Browse 429 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6693075

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6685944

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680291

Modified ciliary neurotrophic factor, method of making and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6642363

Polymers containing polysaccharides such as alginates or modified alginates

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620927

Thiol-modified hyaluronan

ANIKA THERAPEUTICS, INC. · Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6600012

Lipid-modified muc-1 derivatives

Biomira, Inc. · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566326

Chemically modified hemoglobin for burn shock resuscitation

The Regents of the University of California · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6521417

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500640

Nucleic acid molecules encoding modified dorsal tissue affecting factor

The Regents of the University of California · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6472178

Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6440702

Nucleic acids encoding modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6410510

Administration modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6390821

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6284536

Modified immunoglobin molecules and methods for use thereof

The Regents of the University of California · Granted Tue Sep 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165781

Modified adeno-associated virus vector capable of expression from a novel promoter

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6096727

Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide

ANIKA THERAPEUTICS, INC. · Granted Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6075007

Modified noggin polypeptide and compositions

THE REGENTS OF THE UNIV. OF CALIFORNIA · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6072072

Compounds for preparing modified hemoglobin

Montefiore Medical Center · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060505

Method of treating cancer using C-26 modified bryostatin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6019981

Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6017882

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired